BlackRock Investment Management’s EnteroMedics Inc. ETRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-17
Closed -$1K 4294
2016
Q1
$1K Hold
17
﹤0.01% 4057
2015
Q4
$2K Buy
17
+3
+21% +$622 ﹤0.01% 4047
2015
Q3
$4K Buy
14
+4
+40% +$1.28K ﹤0.01% 4018
2015
Q2
$7K Hold
10
﹤0.01% 3889
2015
Q1
$10K Buy
10
+1
+11% +$1.21K ﹤0.01% 3681
2014
Q4
$14K Hold
9
﹤0.01% 3574
2014
Q3
$12K Hold
9
﹤0.01% 3617
2014
Q2
$15K Buy
+9
New +$16.8K ﹤0.01% 3510

Other funds holding ETRM

BlackRock Investment Management's ETRM Position: Q2 2016 in Review

BlackRock Investment Management sold out of EnteroMedics Inc. (ETRM) in Q2 2016, closing a stake of 17 shares — an estimated $1K sold.

BlackRock Investment Management first reported a position in ETRM in Q2 2014 and held it in 8 quarters. The position peaked at $15K in Q2 2014. 24 funds tracked by Wall St. Rank hold ETRM as of Q2 2016.

  • BlackRock Investment Management reported no remaining EnteroMedics Inc. position as of Q2 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 17 EnteroMedics Inc. shares in Q2 2016, an estimated $1K.
  • BlackRock Investment Management first reported a position in EnteroMedics Inc. in Q2 2014 and held it in 8 quarters.
  • BlackRock Investment Management's EnteroMedics Inc. position peaked at $15K in Q2 2014.
  • 24 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.